Clare J. Twist

Associate Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital

Professional Education

Internship: Children's Memorial Hospital (1988) IL

Residency: Children's Memorial Hospital (1990) IL

Fellowship: Children's Hospital Boston (1993) MA

Board Certification: Pediatric Hematology-Oncology, American Board of Pediatrics (1994)

Medical Education: Albany Medical Center (1987) NY

Fellowship, Children's Hospital, Boston/DFCI, Pediatric Hematology & Oncology (1993)

Residency, Children's Memorial Hospital, Pediatrics (1990)

M.D., Albany Medical College, Medicine (1987)

M.S., SUNY Buffalo, Immunology (1984)

B.S., University of Notre Dame, Pre-professional (1982)

Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia
Liedtke, M., Twist, C. J., Medeiros, B. C., Gotlib, J. R., Berube, C., & Coutre, S. E. (2012). Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 97(1), 30-37.

Outcome for Children Treated for Relapsed or Refractory Acute Myelogenous Leukemia (rAML): A Therapeutic Advances in Childhood Leukemia (TACL) Consortium Study
Gorman, M. F., Ji, L., Ko, R. H., Barnette, P., Bostrom, B., & Loh, M. L. (2010). Outcome for Children Treated for Relapsed or Refractory Acute Myelogenous Leukemia (rAML): A Therapeutic Advances in Childhood Leukemia (TACL) Consortium Study. PEDIATRIC BLOOD & CANCER, 55(3), 421-429.

Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study
Ko, R. H., Ji, L., Barnette, P., Bostrom, B., Hutchinson, R., & Loh, M. L. (2010). Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study. JOURNAL OF CLINICAL ONCOLOGY, 28(4), 648-654.

Treatment of Recurrent Post-transplant Lymphoproliferative Disorder (PTLD) of the Central Nervous System (CNS) with High-dose Methotrexate (HD-MTX)
Twist, C. J., KJELSON, L., MCKENNEY, A., Bonham, C. A., Esquivel, C., & Castillo, R. O. (2009). Treatment of Recurrent Post-transplant Lymphoproliferative Disorder (PTLD) of the Central Nervous System (CNS) with High-dose Methotrexate (HD-MTX). XI INTERNATIONAL SMALL BOWEL TRANSPLANT SYMPOSIUM, 116-121.

Detection of Isolated Tumor Cells in Neuroblastoma by Immunohistochemical Analysis in Bone Marrow Biopsy Specimens Improved Detection With Use of beta-Catenin
Krishnan, C., Twist, C. J., Fu, T., & Arber, D. A. (2009). Detection of Isolated Tumor Cells in Neuroblastoma by Immunohistochemical Analysis in Bone Marrow Biopsy Specimens Improved Detection With Use of beta-Catenin. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 131(1), 49-57.

Precursor B-Cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis
O'Brien, M. M., Lee-Kim, Y., George, T. I., McClain, K. L., Twist, C. J., & Jeng, M. (2008). Precursor B-Cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis. PEDIATRIC BLOOD & CANCER, 50(2), 381-383.

I-123 MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma
Iagaru, A., Peterson, D., Quon, A., Dutta, S., Twist, C., & Albanese, C. (2008). I-123 MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma. MOLECULAR IMAGING AND BIOLOGY, 10(1), 19-23.

Effects of human monoclonal antibody 216 on B-progenitor acute lymphoblastic leukemia in vitro
Bieber, M. M., Twist, C. J., Bhat, N. M., & Teng, N. Nh. (2007). Effects of human monoclonal antibody 216 on B-progenitor acute lymphoblastic leukemia in vitro. PEDIATRIC BLOOD & CANCER, 48(4), 380-386.

A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: A study of the Children's Oncology Group
Osenga, K. L., Hank, J. A., Albertini, M. R., Gan, J., Sternberg, A. G., & Sondel, P. M. (2006). A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: A study of the Children's Oncology Group. CLINICAL CANCER RESEARCH, 12(6), 1750-1759.

The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives
London, W. B., Boni, L., Simon, T., Berthold, F., Twist, C., & De Bernardi, B. (2005). The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives. CANCER LETTERS, 228(1-2), 257-266.

Assessment of lymphadenopathy in children
Twist, C. J., & Link, M. P. (2002). Assessment of lymphadenopathy in children. PEDIATRIC CLINICS OF NORTH AMERICA, 49(5), 1009-?.

A case from Stanford University. Neuroblastoma with diffuse bone marrow involvement.
Durski, J. M., Twist, C. J., & Goris, M. (2001). A case from Stanford University. Neuroblastoma with diffuse bone marrow involvement. Nuclear medicine review. Central & Eastern Europe, 4(1), 61-62.

The mouse Cd83 gene: structure, domain organization, and chromosome localization
Twist, C. J., Beier, D. R., Disteche, C. M., Edelhoff, S., & Tedder, T. F. (1998). The mouse Cd83 gene: structure, domain organization, and chromosome localization. IMMUNOGENETICS, 48(6), 383-393.

Hurler syndrome: II. Outcome of HLA genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children
Peters, C., Shapiro, E. G., Anderson, J., Henslee-Downey, P. J., Klemperer, M. R., & Krivit, W. (1998). Hurler syndrome: II. Outcome of HLA genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. BLOOD, 91(7), 2601-2608.

ISOLATION OF MOUSE T-CELL LYMPHOMA LINES FROM DIFFERENT LONG-TERM INTERLEUKIN 2-DEPENDENT CULTURES
Giglia, J. S., OVAK, G. M., Yoshida, M. A., Twist, C. J., Jeffery, A. R., & Pauly, J. L. (1985). ISOLATION OF MOUSE T-CELL LYMPHOMA LINES FROM DIFFERENT LONG-TERM INTERLEUKIN 2-DEPENDENT CULTURES. CANCER RESEARCH, 45(10), 5027-5034.

STUDIES OF CULTURED HUMAN LYMPHOCYTES-T .2. INITIATION OF PAIRED T-CELL AND B-CELL LINES FROM HEALTHY DONORS
Pauly, J., Russell, C. W., PIRELA, D. L., Twist, C. J., REINERTSON, R., & Minowada, J. (1983). STUDIES OF CULTURED HUMAN LYMPHOCYTES-T .2. INITIATION OF PAIRED T-CELL AND B-CELL LINES FROM HEALTHY DONORS. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 172(3), 283-290.

STUDIES OF CULTURED HUMAN LYMPHOCYTES-T .4. PRODUCTION OF SERUM-FREE AND MITOGEN-FREE SUPERNATANTS HAVING HIGH-LEVELS OF THE HUMAN T-CELL GROWTH-PROMOTER INTERLEUKIN-2
Pauly, J. L., Twist, C. J., PIRELA, D. L., REINERTSON, R. R., Callahan, J. J., & Russell, C. W. (1983). STUDIES OF CULTURED HUMAN LYMPHOCYTES-T .4. PRODUCTION OF SERUM-FREE AND MITOGEN-FREE SUPERNATANTS HAVING HIGH-LEVELS OF THE HUMAN T-CELL GROWTH-PROMOTER INTERLEUKIN-2. IRCS MEDICAL SCIENCE-BIOCHEMISTRY, 11(1), 77-78.

STUDIES OF CULTURED HUMAN LYMPHOCYTES-T .6. CULTURE FLASK COMPOSITION MARKEDLY AFFECTS IL-2-DEPENDENT T-CELL PROLIFERATION AS DEFINED IN COMPARATIVE STUDIES OF GLASS, POLYSTYRENE AND POLYMETHYLPENTENE VESSELS
Pauly, J. L., OVAK, G. M., Twist, C. J., & RUSSEL, C. W. (1983). STUDIES OF CULTURED HUMAN LYMPHOCYTES-T .6. CULTURE FLASK COMPOSITION MARKEDLY AFFECTS IL-2-DEPENDENT T-CELL PROLIFERATION AS DEFINED IN COMPARATIVE STUDIES OF GLASS, POLYSTYRENE AND POLYMETHYLPENTENE VESSELS. IRCS MEDICAL SCIENCE-BIOCHEMISTRY, 11(6), 534-535.

STUDIES OF CULTURED HUMAN LYMPHOCYTES-T .3. A QUANTITATIVE ASSAY OF THE HUMAN T-CELL GROWTH-PROMOTING LYMPHOKINE INTERLEUKIN-2
Pauly, J. L., Twist, C. J., PIRELA, D. L., REINERTSON, R. R., Callahan, J. J., & Russell, C. W. (1982). STUDIES OF CULTURED HUMAN LYMPHOCYTES-T .3. A QUANTITATIVE ASSAY OF THE HUMAN T-CELL GROWTH-PROMOTING LYMPHOKINE INTERLEUKIN-2. IRCS MEDICAL SCIENCE-BIOCHEMISTRY, 10(11), 899-900.